MB
MPM BioImpact Portfolio holdings
AUM
$577M
1-Year Est. Return
8.33%
1 Year Est. Return
+8.33%
AUM
$582M
AUM Growth
-$123M
(-17%)
Holding
53
Top Buys
| 1 | +$33.3M | |
| 2 | +$16.5M | |
| 3 | +$11.1M | |
| 4 |
United Therapeutics
UTHR
|
+$11.1M |
| 5 |
Janux Therapeutics
JANX
|
+$9.1M |
Top Sells
| 1 | +$26.9M | |
| 2 | +$24.4M | |
| 3 | +$22M | |
| 4 |
Scholar Rock
SRRK
|
+$18M |
| 5 |
Akero Therapeutics
AKRO
|
+$12.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Disc Medicine
IRON
$3.13B
| – | – |
-346,401
|
|
||
52
Mirum Pharmaceuticals
MIRM
$3.69B
| – | – |
-589,579
|
|
||
|
53
Scholar Rock
SRRK
$2.69B
| – | – |
-416,144
|
|